Latest filing published 29 Nov 2012 for Navidea Biopharmaceuticals, INC., €6.0M.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Platinum-Montaur Life Sciences, LLC: trading record in brief
Platinum-Montaur Life Sciences, LLC discloses dealings in 2 companies, chiefly Navidea Biopharmaceuticals, Inc. and Dais Analytic Corp. The record holds 16 filings, for trades running from 12 March 2009 to 27 November 2012.
Market trades split into 1 purchase (€74k) and 13 sales (€2.2M). Netting one side against the other leaves €2.1M of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2012 alone, the filings show 1 purchase and 8 sales.
The newest entry dates from 29 November 2012: a transaction of €6.0M, in Navidea Biopharmaceuticals, Inc. The last insider purchase was made public on 9 November 2012, 5,112 days ago. Filings reach the SEC (Form 4) feed a median of 50 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Platinum-Montaur Life Sciences, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,001,860 shares@ US$2.58Common Stock, par value $0.001SEC:0001263987-12-000007:0
- 205,521 shares@ US$3.80Common Stock, par value $0.001SEC:0001140361-12-046566:0
- 64,900 shares@ US$3.78Common Stock, par value $0.001SEC:0001140361-12-046566:1
- 2,200 shares@ US$3.71Common Stock, par value $0.001SEC:0001140361-12-046566:2
- 118,731 shares@ US$3.61Common Stock, par value $0.001SEC:0001140361-12-046566:3
- 20,500 shares@ US$3.75Common Stock, par value $0.001SEC:0001140361-12-046566:4
- 269,919 shares@ US$3.69Common Stock, par value $0.001SEC:0001140361-12-046566:5
- 21,700 shares@ US$3.22Common Stock, par value $0.001SEC:0001140361-12-046566:6
- 4,911 shares@ US$3.24Common Stock, par value $0.001SEC:0001140361-12-046566:7
- 37,030 shares@ US$2.56Common Stock, par value $0.001SEC:0001140361-12-046566:8Canonical exit: 8 Jan 2013 (T+90)
- 3,324,740 shares@ US$0.20Common StockSEC:0001140361-09-024643:0
- 2,040 shares@ US$1.00Common StockSEC:0001140361-09-024643:1
- 8,500 shares@ US$1.03Common StockSEC:0001140361-09-024643:2
- 61,293 shares@ US$1.73Common StockSEC:0001140361-09-024643:3
- 13,550 shares@ US$1.10Common StockSEC:0001140361-09-024643:4
- 1,153 shares@ US$1.05Common StockSEC:0001140361-09-024643:5
16 of 16 declarations